Long-term support of patients receiving a left ventricular assist device for advanced heart failure: a follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System [TX & MCS]

CONCLUSIONS Owing to the low rate of heart transplants, a significant number of patients receiving a left ventricular assist device as a bridge to transplant remain on support for prolonged periods, often exceeding 2, 3 and even 4 years. Real-world use of the HVAD system continues to show excellent outcomes for patients on the device, including those on support beyond 2 years.

http://ejcts.oxfordjournals.org/cgi/content/short/50/5/834?rss=1

Source: European Journal of Cardio-Thoracic Surgery - November 3, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Schmitto, J. D., Zimpfer, D., Fiane, A. E., Larbalestier, R., Tsui, S., Jansz, P., Simon, A., Schueler, S., Strueber, M. Tags: Myocardial protection, Peripheral vascular, Aorto-iliac disease TX & amp; MCS Source Type: research